CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...
Patients with immune checkpoint inhibitor colitis initially treated with high-dose glucocorticoids had a higher risk for ...
AnaptysBio ends its ulcerative colitis trial after rosnilimab misses key goals, focusing resources on rheumatoid arthritis ...
The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...
Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh. The pharmaceutical company said Monday ...
Horsham: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking to expand approval of ...
James Cook University (JCU) researchers have discovered that the same chemical compounds produced by mountain-top plants to help them survive climate change in North Queensland may also hold promise ...
As mentioned, Crohn’s colitis is a subtype of Crohn’s disease that only affects the colon. “We typically label Crohn’s based on what part of the gastrointestinal tract it affects,” says Sara ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures — severity, frequency and stool deferral time — reflecting the spectrum of its ...
Adult patients with cancer who had adenomas at baseline and immune checkpoint inhibitor-mediated diarrhea and colitis faced a greater risk for further colon adenoma development, according to study ...
Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to survive ...